Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$33.41 -0.11 (-0.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Lakefront Biotherapeutics (LKFT) Restructuring Costs (2014)

Updated

Lakefront Biotherapeutics (LKFT) posted Restructuring Costs of -$874,883 for the quarter ended Dec 31, 2014.

Analysis

Lakefront Biotherapeutics (LKFT) Restructuring Costs (2014) Analysis & Trends

For the year ended Dec 31, 2014, Lakefront Biotherapeutics' Restructuring Costs came in at -$889,300.

  • In prior years, Lakefront Biotherapeutics' Restructuring Costs was -$385,146 in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Lakefront Biotherapeutics 2.19 Bn 1.29 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -874,883.44
Sep 30, 2014 -796,374.86
API Access

Lakefront Biotherapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=LKFT&period=max&api_key=YOUR_API_KEY